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Background: Due to the substantial increase in beam-on time of high energy intensity-modulated radiotherapy
(>10 MV) techniques to deliver the same target dose compared to conventional treatment techniques, an
increased dose of scatter radiation, including neutrons, is delivered to the patient. As a consequence, an increase
in second malignancies may be expected in the future with the application of intensity-modulated radiotherapy.
It is commonly assumed that the neutron dose equivalent scales with the number of monitor units.
Methods: Measurements of neutron dose equivalent were performed for an open and an intensity-modulated
field at four positions: inside and outside of the treatment field at 0.2 cm and 15 cm depth, respectively.
Results: It was shown that the neutron dose equivalent, which a patient receives during an intensity-modulated
radiotherapy treatment, does not scale with the ratio of applied monitor units relative to an open field irradiation.
Outside the treatment volume at larger depth 35% less neutron dose equivalent is delivered than expected.
Conclusions: The predicted increase of second cancer induction rates from intensity-modulated treatment
techniques can be overestimated when the neutron dose is simply scaled with monitor units.Background
With the application of new radiation treatment modal-
ities such as intensity-modulated radiotherapy (IMRT)
or intensity-modulated arc-therapy, increased tumor
control probabilities are anticipated. However, with the
application of these treatment techniques also a larger
number of secondary cancers is expected. Some scien-
tists believe that we will see an increase in second malig-
nancies due to the substantial increase in beam-on time
of IMRT techniques to deliver the same target dose
compared to conventional treatment techniques [1,2].
A consequence of the extended beam-on time is an
increased dose of scatter radiation, including neutrons,
which affects the whole patient. The neutrons could lead
to a considerable contribution to the integral dose, in
particular, since neutrons have a large quality factor and
thus even a small physical dose can result in substantial
biological effects.
Most measurements and estimates of neutron dose equi-
valent from radiotherapy treatments found in literature are* Correspondence: uschneider@vetclinics.uzh.ch
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reproduction in any medium, provided the orusually given in operational dose quantities, which repre-
sent effective dose and thus a person risk. A compilation
of current literature is listed in the review article by Xu
et al. [3]. It should be noted that the neutron dose is
only one contribution to integral dose and person risk.
Others are for example dose contributions from scat-
tered photons, leakage radiation, products from inelastic
nuclear reactions and imaging modalities.
In this report neutron detectors were used, which were
calibrated to measure local neutron dose equivalent, at
different depths in a solid water phantom in- and out-
side of the primary radiation field for an open and
intensity-modulated radiation field.Methods
The neutron dose measurements were performed with a
detector system consisting of a PADC (poly(allyl diglycol
carbonate)) track etch detector (Thermo Fisher Scientific
Inc., Waltham MA, USA) with 2 mm thick radiators
(polyethylene and polyethylene with lithium) on both
sides. The detectors were provided and read-out by the
Division for Radiation Safety and Security of the Paul
Scherrer Institut (PSI) [4,5].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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large RW3 solid water phantom (PTW, Freiburg, Ger-
many). A specifically manufactured holder (acrylic
glass) was used to irradiate three detectors simultan-
eously in order to improve statistics. The experimental
setup is depicted in Figure 1. Four measurement posi-
tions were chosen: in the radiation field at 0.2 cm depth
(D1) as well as in 15 cm depth (D2) and in gun direction
outside of the treatment field at 0.2 cm (D3) and 15 cm
(D4) depth, respectively. The in-field detectors (D1, D2)
were placed on the central ray of the radiation field, the
out-of-field detectors (D3, D4) 20 cm away from the
central ray.
A linear accelerator (Varian Medical System, Palo Alto
CA, USA) was used to produce a photon radiation beam
with a nominal energy of 16 MV, having a tissue phan-
tom ratio TPR20,10 at 20 cm/10 cm depth of 0.760. Two
irradiation techniques have been used. The first field
was an open radiation field delivering 75 monitor units
(MU) and a total dose of 0.592 Gy in 15 cm depth. The
field size of 10 x 10 cm2 was defined by the jaws and theFigure 1 Experimental set-up. A 30 x 30 x 30 cm3 RW3 solid water
cube was irradiated with a 10 x 10 cm2 field with a nominal energy
of 16 MV at a source surface distance of 85 cm. The radiation beam
was placed such that the central ray was 5 cm from the phantom
border (isocenter was located at 15 cm depth). The PADC detectors
were placed horizontally 5 cm from the edge of the phantom. The
numbers in the boxes indicate the ratio of neutron dose equivalent
from the IMRT field relative to the open field for the same absorbed
dose at position D2.multileaf collimator (MLC) was retracted. The second
radiation field was intensity-modulated, with a 2.32 cm
sweeping MLC gap of 10 cm lateral dimension. With
the IMRT field the same dose was delivered as with the
open field, but with 225 monitor units. The jaws were
positioned to form a 10 x 10 cm2 field. The MU-ratio
between IMRT and open field was three. Since the sensi-
tivity of the PADC detectors is optimal in a limited dose
range, the detectors at the different positions were irra-
diated with different doses. For the measurement pos-
ition D1, the radiation field was applied two times, for
the positions D2 and D3 six times and for D4 120 times.
The detector output given in tracks per area was first
calibrated into personal dose equivalent Hp(10). For
this purpose, a subset of the PADC detectors from the
measurement batch was mounted on an ISO water slab
phantom and irradiated with neutrons from an 241Am-
Be neutron source. The dose at the detector position
was determined with a Berthold LB6411 neutron dose
rate meter calibrated at the Physikalisch-Technische
Bundesanstalt in Braunschweig, Germany [6], which is
used as a secondary standard at PSI. The resulting cali-
bration factor for the used batch of PADC detectors was
16.39  10-3 mSv cm2 ±36% (one standard deviation).
The radiation quality used in the experiment was a
photon beam with a nominal energy of 16 MV, which
produces neutrons with a different energy distribution
than the 241Am-Be calibration source. To account for
this difference, Monte Carlo simulated neutron spectra
in water of a photon beam from a Varian linear acceler-
ator were taken from Kry et al. [7,8]. The detector
response normalized to the 241Am-Be neutron spectrum
from [9] was convolved with the normalized neutron
spectra simulated in- and outside of the radiation field
resulting in calibration coefficients for the neutron spec-
tra at the four detector positions, which are listed in
Table 1. This field calibration procedure is described by
Hälg et al. [8].
Results
The measurement series were performed once for the
open field and twice for the IMRT field, leading to three
and six measurement values per location, respectively.
The average value of the measurements at each location
was used to report the results.
The measured neutron dose equivalents at the four
locations for the two techniques are listed in Table 2.
The ratio of the neutron dose equivalent from the IMRT
treatment to the dose resulting from the open field ir-
radiation is shown in the boxes of Figure 1 at the four
positions. In the treatment field itself the ratio drops
from 1.6 at the surface to 1.0 at 15 cm depth. Outside
the treatment field the ratio is 2.4 at the surface and 1.9
at 15 cm depth.
Table 1 Calibration factors for converting tracks per cm2
into neutron dose equivalent in mSv for the different







Neutron dose equivalent H
(16 MV photons)/HP(10) (Am-Be)
in-field out-of-field
0.2 16.39  10-3 0.91 0.96
15.0 16.39  10-3 0.71 0.71
The second column represents the initial absolute calibration from tracks per
cm2 into mSv cm2, performed in the 241Am-Be neutron field. The third column
contains the calibration factors considering the spectral changes with depth.
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The uncertainty of the calibration and readout of the
PADC detectors was estimated by the standard deviation
of the readout of two subsets of the detector batch which
were used as background detectors or have been irradiated
with neutrons from the 241Am-Be source for the absolute
calibration. It was calculated to be σ= 36%. This was veri-
fied by the statistical deviations of the minimum or max-
imum readout to the mean value of the three repeated
measurements at each measurement position, which were
in the range of −17% to +30% with an average of less than
10%. The error of the mean was calculated using the
Student’s t-distribution ΔD= t  σ/√n=27% with n= 3 and
a corresponding t = 1.32. The total uncertainty was then
calculated by error propagation for the ratios of the open
and the intensity-modulated field doses. The overall un-
certainty of the dose ratios was 39%.
In addition to the detector batch variation of 36% an
uncertainty of 17% comes from three sources. One
source of around 5% comes from the spectral difference
of the calibration conditions (neutrons from an Am-Be
source) and the open photon radiotherapy beam.
Another source of around 15% comes from the spectral
change with depth in the phantom. Both of these uncer-
tainties apply more or less in a similar way to the open
and the MLC field and were therefore not considered
for the error estimate of the dose ratios. The residual
uncertainty of maximal 7% comes from the differences
in fluence between the open and the MLC field which
was not accounted for, as it is much smaller than the
36% batch uncertainty.Table 2 Neutron dose equivalent in mSv per treatment





in mSv/Gy for an open field
Neutron dose equivalent
in mSv/Gy for an IMRT field
in-field out-of-field in-field out-of-field
0.2 2.8 1.0 4.5 2.4
15.0 0.20 0.015 0.20 0.029
Dose was prescribed to measurement point D2.An IMRT treatment delivers more monitor units than
a conventional irradiation due to the realization of the
intensity modulation. As a consequence, beam-on time
is longer for the same delivered dose. Commonly it is
assumed that neutron dose equivalent scales with the
number of applied monitor units for a radiotherapy
treatment irrespectively of the used treatment technique
[1,2]. The measurements presented in this report indi-
cate that this may only be true for superficial tissues out-
side of the treatment field. Deeper lying tissues outside
the treatment volume receive around 35% less neutron
dose equivalent than expected (three times expected and
around two times observed). In the treated volume
the dose reduction is even more pronounced with a 45%
reduction at the surface and a 65% reduction in larger
depth. However, it should be noted here that the irra-
diated volume is in general much smaller than the body
volume which receives only scatter dose. Therefore,
if it is assumed that cancer induction is a function
of dose and irradiated volume, the neutron dose reduc-
tion in the irradiated volume might not have a large
impact. In addition the neutron dose equivalent must be
viewed always in relation to the primary dose distribu-
tion, which is several orders of magnitude larger in the
treated volume.
A possible explanation for the measured difference in
scaling of the neutron dose with applied monitor units
for open and intensity-modulated fields could be the
interplay between neutron production and neutron
shielding of the multileaf collimator when used in IMRT.
Kry et al. [10] found in Monte Carlo simulations of
neutron production in a Varian linear accelerator head
that the MLC can act as a neutron absorber where the
primary photon beam is shielded by the jaws. Zanini
et al. [11] did a Monte Carlo study on the photoneutron
fields of a Varian linear accelerator operating at a nom-
inal energy of 18 MV. They determined neutron spectra
at different locations (inside and outside of the primary
field) for different collimation settings. The spectra
simulated in that study at 3 cm (as in-field) and 15 cm
(as out-of-field) laterally from the isocenter were used to
estimate the expected readout of the PADC detectors
used in this work. For this purpose the spectra were
convolved with the energy dependent detector response
function of the PADC detectors determined by PSI
[4,5,9]. The absolute neutron fluence per cm2 per Gy
obtained by Zanini et al. for the static MLC field was
multiplied by a factor of three to account for the elon-
gated beam-on time for intensity modulation. The calcu-
lated PADC response includes not only the spectral
change, but also effects like for example the absorption of
neutrons by the MLC. The simulated detector response
yielded a neutron dose ratio of 2.4 for the in-field
spectrum and 2.0 for the out-of-field spectrum at the
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surements of this study. In the work by Zanini et al.
it was also shown that for equal field sizes the amount
of neutron production in the MLC is smaller than in
the jaws.
The neutron spectra simulated in the study by Zanini
et al. show a slight shift towards lower energies for the
field using the MLC when compared to the open field.
This shift lowers also the mean energy, which could be
responsible for the change of the ratio between the open
field and the intensity-modulated field with depth in
the phantom seen in this study, as the moderation of
neutrons is energy dependent. Dedicated Monte Carlo
simulations would be necessary to assess this in detail.
Conclusions
The findings of this study indicate that the number of
applied monitor units during a radiotherapy treatment
alone is not predictive for the neutron dose equivalent
the patient receives. Outside the treatment volume in
larger depth 35% less neutron dose equivalent was deliv-
ered than expected for a MU scaling of a factor of three
to deliver the same dose to the target for IMRT com-
pared to the open field. As a consequence, the predicted
increase of second cancer induction rates from intensity-
modulated treatment techniques at large photon beam
energies might have been overestimated. The neutron
dose to the patient is dependent on several parameters,
such as the type and material of the multileaf collimator
and the photon energy, which were not investigated in
this work and should be included in further studies.
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